{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:01:33Z","timestamp":1760061693276},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2677-3","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T13:25:03Z","timestamp":1471872303000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Michael J.","family":"Overman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harris S.","family":"Soifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron Joel","family":"Schueneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Joe","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"Adsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Saka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Neishaboori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A.","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauri","family":"Varadhachary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"issue":"3","key":"2677_CR1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/00000658-191303000-00007","volume":"57","author":"GW Outerbridge","year":"1913","unstructured":"Outerbridge GW. VII. Carcinoma of the Papilla of Vater. Ann Surg. 1913;57(3):402\u201326.","journal-title":"Ann Surg"},{"key":"2677_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/1471-2407-13-428","volume":"13","author":"P Bronsert","year":"2013","unstructured":"Bronsert P, Kohler I, Werner M, Makowiec F, Kuesters S, Hoeppner J, Hopt UT, Keck T, Bausch D, Wellner UF. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin. BMC Cancer. 2013;13:428.","journal-title":"BMC Cancer"},{"issue":"10","key":"2677_CR3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","volume":"31","author":"DK Chang","year":"2013","unstructured":"Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, et al. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol. 2013;31(10):1348\u201356.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2677_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","volume":"85","author":"W Kimura","year":"1994","unstructured":"Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res. 1994;85(2):161\u20136.","journal-title":"Jpn J Cancer Res"},{"key":"2677_CR5","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","volume":"38","author":"DC Ang","year":"2014","unstructured":"Ang DC, Shia J, Tang LH, Katabi N, Klimstra DS. The Utility of Immunohistochemistry in Subtyping Adenocarcinoma of the Ampulla of Vater. Am J Surg Pathol. 2014;38:1371\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2677_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/01.pas.0000149708.12335.6a","volume":"29","author":"PG Chu","year":"2005","unstructured":"Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol. 2005;29(3):359\u201367.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2677_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PAI.0b013e3181a75e6d","volume":"18","author":"GG Anderson","year":"2010","unstructured":"Anderson GG, Weiss LM. Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance. Appl Immunohistochem Mol Morphol. 2010;18(1):3\u20138.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"2677_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jmoldx.2012.10.001","volume":"15","author":"LM Weiss","year":"2013","unstructured":"Weiss LM, Chu P, Schroeder BE, Singh V, Zhang Y, Erlander MG, Schnabel CA. Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors. J Mol Diagn. 2013;15(2):263\u20139.","journal-title":"J Mol Diagn"},{"issue":"7","key":"2677_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/PAS.0b013e31828309c4","volume":"37","author":"CR Handorf","year":"2013","unstructured":"Handorf CR, Kulkarni A, Grenert JP, Weiss LM, Rogers WM, Kim OS, Monzon FA, Halks-Miller M, Anderson GG, Walker MG, et al. A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors. Am J Surg Pathol. 2013;37(7):1067\u201375.","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"2677_CR10","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1200\/JCO.2008.17.9762","volume":"27","author":"FA Monzon","year":"2009","unstructured":"Monzon FA, Lyons-Weiler M, Buturovic LJ, Rigl CT, Henner WD, Sciulli C, Dumur CI, Medeiros F, Anderson GG. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. J Clin Oncol. 2009;27(15):2503\u20138.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2677_CR11","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1158\/1078-0432.CCR-10-2599","volume":"17","author":"GR Varadhachary","year":"2011","unstructured":"Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, et al. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res. 2011;17(12):4063\u201370.","journal-title":"Clin Cancer Res"},{"issue":"0","key":"2677_CR12","first-page":"1","volume":"0","author":"CA Schnabel","year":"2012","unstructured":"Schnabel CA, Erlander MG. Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors. Exp Opin Med Diagn. 2012;0(0):1\u201313.","journal-title":"Exp Opin Med Diagn"},{"key":"2677_CR13","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1158\/1078-0432.CCR-12-0920","volume":"1","author":"SE Kerr","year":"2012","unstructured":"Kerr SE, Schnabel CA, Sullivan PS, Zhang Y, Singh V, Carey B, Erlander M, Highsmith WE, Dry SM, Brachtel E. Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier. Clin Cancer Res. 2012;1:3952\u201360.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2677_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1750-3639.2002.tb00426.x","volume":"12","author":"H Wang","year":"2002","unstructured":"Wang H, Zhang W, Fuller GN. Tissue microarrays: applications in neuropathology research, diagnosis, and education. Brain Pathol. 2002;12(1):95\u2013107.","journal-title":"Brain Pathol"},{"key":"2677_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jmoldx.2011.04.004","volume":"13","author":"MG Erlander","year":"2011","unstructured":"Erlander MG, Ma XJ, Kesty NC, Bao L, Salunga R, Schnabel CA. Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. J Mol Diagn. 2011;13:493\u2013503.","journal-title":"J Mol Diagn"},{"key":"2677_CR16","first-page":"65","volume":"8","author":"H Li","year":"2003","unstructured":"Li H, Luan Y. Kernel Cox regression models for linking gene expression profiles to censored survival data. Pac Symp Biocomput. 2003;8:65\u201376.","journal-title":"Pac Symp Biocomput"},{"issue":"5","key":"2677_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrc3721","volume":"14","author":"VN Kristensen","year":"2014","unstructured":"Kristensen VN, Lingjaerde OC, Russnes HG, Vollan HK, Frigessi A, Borresen-Dale AL. Principles and methods of integrative genomic analyses in cancer. Nat Rev Cancer. 2014;14(5):299\u2013313.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2677_CR18","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","volume":"26","author":"RG Amado","year":"2008","unstructured":"Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(10):1626\u201334.","journal-title":"J Clin Oncol"},{"issue":"9742","key":"2677_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687\u201397.","journal-title":"Lancet"},{"issue":"26","key":"2677_CR20","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364(26):2507\u201316.","journal-title":"N Engl J Med"},{"issue":"8","key":"2677_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989;320(8):479\u201384.","journal-title":"N Engl J Med"},{"issue":"1","key":"2677_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/bjc.2014.211","volume":"111","author":"C Tourneau Le","year":"2014","unstructured":"Le Tourneau C, Paoletti X, Servant N, Bieche I, Gentien D, Rio Frio T, Vincent-Salomon A, Servois V, Romejon J, Mariani O, et al. Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial. Br J Cancer. 2014;111(1):17\u201324.","journal-title":"Br J Cancer"},{"issue":"8","key":"2677_CR23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1470-2045(14)70212-8","volume":"15","author":"D Malka","year":"2014","unstructured":"Malka D, Cervera P, Foulon S, Trarbach T, de la Fouchardiere C, Boucher E, Fartoux L, Faivre S, Blanc JF, Viret F, et al. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial. Lancet Oncol. 2014;15(8):819\u201328.","journal-title":"Lancet Oncol"},{"issue":"11","key":"2677_CR24","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1097\/PAS.0b013e31826399d8","volume":"36","author":"V Adsay","year":"2012","unstructured":"Adsay V, Ohike N, Tajiri T, Kim GE, Krasinskas A, Balci S, Bagci P, Basturk O, Bandyopadhyay S, Jang KT, et al. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol. 2012;36(11):1592\u2013608.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2677_CR25","doi-asserted-by":"publisher","first-page":"e65144","DOI":"10.1371\/journal.pone.0065144","volume":"8","author":"MJ Overman","year":"2013","unstructured":"Overman MJ, Zhang J, Kopetz S, Davies M, Zhi-Qin J, Stemke-Hale K, Rummele P, Pilarsky C, Grutzmann R, Hamilton S, et al. Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome. PLoS One. 2013;8(6):e65144.","journal-title":"PLoS One"},{"issue":"1","key":"2677_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/bjc.2015.172","volume":"113","author":"A Schueneman","year":"2015","unstructured":"Schueneman A, Goggins M, Ensor J, Saka B, Neishaboori N, Lee S, Maitra A, Varadhachary G, Rezaee N, Wolfgang C, et al. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma. Br J Cancer. 2015;113(1):64\u20138.","journal-title":"Br J Cancer"},{"issue":"4","key":"2677_CR27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5858\/2006-130-465-MCOHCU","volume":"130","author":"XJ Ma","year":"2006","unstructured":"Ma XJ, Patel R, Wang X, Salunga R, Murage J, Desai R, Tuggle JT, Wang W, Chu S, Stecker K, et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med. 2006;130(4):465\u201373.","journal-title":"Arch Pathol Lab Med"},{"key":"2677_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2350-5-24","volume":"5","author":"ZM Ahmed","year":"2004","unstructured":"Ahmed ZM, Li XC, Powell SD, Riazuddin S, Young TL, Ramzan K, Ahmad Z, Luscombe S, Dhillon K, MacLaren L, et al. Characterization of a new full length TMPRSS3 isoform and identification of mutant alleles responsible for nonsyndromic recessive deafness in Newfoundland and Pakistan. BMC Med Genet. 2004;5:24.","journal-title":"BMC Med Genet"},{"issue":"2","key":"2677_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/10408363.2013.865701","volume":"51","author":"J Dorn","year":"2014","unstructured":"Dorn J, Beaufort N, Schmitt M, Diamandis EP, Goettig P, Magdolen V. Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers. Crit Rev Clin Lab Sci. 2014;51(2):63\u201384.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"Suppl 1","key":"2677_CR30","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1097\/01.hjh.0000467681.47178.d5","volume":"33","author":"L Evenepoel","year":"2015","unstructured":"Evenepoel L, Van Nederveen FH, Oudijk L, Papathomas TG, Restuccia DF, Belt EJ, Franssen GJ, Feelders RA, Van Eeden S, Timmers H, et al. 9b.09: Identification of Markers Predictive for Malignant Behavior of Pheochromocytomas and Paragangliomas. J Hypertens. 2015;33 Suppl 1:e122.","journal-title":"J Hypertens"},{"issue":"24","key":"2677_CR31","first-page":"8614","volume":"63","author":"CA Iacobuzio-Donahue","year":"2003","unstructured":"Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 2003;63(24):8614\u201322.","journal-title":"Cancer Res"},{"issue":"11","key":"2677_CR32","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.15252\/embr.201438622","volume":"15","author":"O Martorell","year":"2014","unstructured":"Martorell O, Barriga FM, Merlos-Suarez A, Stephan-Otto Attolini C, Casanova J, Batlle E, Sancho E, Casali A. Iro\/IRX transcription factors negatively regulate Dpp\/TGF-beta pathway activity during intestinal tumorigenesis. EMBO Rep. 2014;15(11):1210\u20138.","journal-title":"EMBO Rep"},{"key":"2677_CR33","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1038\/ncomms4128","volume":"5","author":"R Nilsson","year":"2014","unstructured":"Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, Kampf C, Huang J, Asplund A, Mootha VK. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun. 2014;5:3128.","journal-title":"Nat Commun"},{"issue":"5","key":"2677_CR34","first-page":"5435","volume":"8","author":"X Rui","year":"2015","unstructured":"Rui X, Li Y, Jin F, Li F. TMPRSS3 is a novel poor prognostic factor for breast cancer. Int J Clin Exp Pathol. 2015;8(5):5435\u201342.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"2677_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"JP Neoptolemos","year":"2012","unstructured":"Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308(2):147\u201356.","journal-title":"JAMA"},{"issue":"18","key":"2677_CR36","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1001\/jama.2012.13952","volume":"308","author":"M Overman","year":"2012","unstructured":"Overman M, Wang H, Varadhachary GR. Adjuvant chemotherapy for resected periampullary adenocarcinoma. JAMA. 2012;308(18):1855. author reply 1855\u20131856.","journal-title":"JAMA"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2677-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2677-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2677-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2677-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T21:11:47Z","timestamp":1657141907000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2677-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2677"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2677-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]},"assertion":[{"value":"4 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"668"}}